Posted on 07/23/2021 7:38:11 AM PDT by CondoleezzaProtege
Johnson & Johnson and AstraZeneca are conducting early stage research into whether potential modifications of their Covid-19 vaccines could reduce or eliminate the risk of rare, but serious, blood clots associated with the shots.
(Excerpt) Read more at cnbc.com ...
MOSCOW, April 14. /TASS/. The Gamaleya Federal Research Center for Epidemiology and Microbiology is ready to share its vaccine purification technologies with other developers to minimize the risk of side effects, the center’s statement published on Wednesday reads. It is noted that on the outcomes of an analysis of the results of clinical trials and mass vaccination with Sputnik V, no cases of venous sinus thrombosis of the human brain were documented. During the production of Sputnik V, a purification technology is used that includes two stages of chromatographic purification and two stages of tangential filtration.
The center explained that any vaccine based on adenoviral vectors has its individual features, and it would not be right to compare such vaccines directly. "Due to this, there are no grounds to extrapolate the safety data acquired during the use of one vaccine on the safety data of other vaccines," the message says.
See also:
Gamaleya researchers used common cold viruses in their vaccine prototype. Notably, they opted for two different adenovirus vectors (rAd26 and rAd5) delivered separately in a first and second dose, 21 days apart.1 Using the same adenovirus for the two doses could lead to the body developing an immune response against the vector and destroying it when the second dose is administered. Two different vectors reduces the chance of this.
To make the vaccine, the adenoviruses are combined with the SARS-CoV-2 spike protein, which prompts the body to make an immune response to it. - BMJ
Ping
They’ll stop using a Live Virus ?
My circle of friends isn’t really all that large. I personally know someone that this vaccine killed. She was a healthy 35 year old.
Well, at least they are worried. They must know something.
“…they opted for two different adenovirus vectors (rAd26 and rAd5) delivered separately in a first and second dose, 21 days apart.1 Using the same adenovirus for the two doses could lead to the body developing an immune response against the vector and destroying it when the second dose is administered. Two different vectors reduces the chance of this….”
******************************************************U
SMART!
Joe is using up the rest of the J&J sending to ice to stab into some illegals.
LOL He cares so much. Can we come in Joe? Yeah, take that. See ya at the grave site. Bye now.
Blood clots, death? Meh.. we’ll think about it.
Serious blood clot issue? Yes. Rare? Not from the doctors’ reports I’ve read.
Sorry to hear that. Too many feel she’s an acceptable loss.
Call these shots clotshots.
The name is short, rhymes, and is easy to remember.
Wonder how much testing they’ll do before they distribute the changes. Oh, that’s right, we’re the guinea pigs...
The vaccine industry is pure evil and fraudulent
Never doubt that for a second
Becoming less rare by the minute
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.